Weyland, Charlotte S. http://orcid.org/0000-0002-1374-7854
Neuberger, Ulf http://orcid.org/0000-0002-0287-6714
Potreck, Arne http://orcid.org/0000-0001-9206-2636
Pfaff, Johannes A. R. http://orcid.org/0000-0003-0672-5718
Nagel, Simon http://orcid.org/0000-0003-2471-6647
Schönenberger, Silvia http://orcid.org/0000-0002-3348-6719
Bendszus, Martin http://orcid.org/0000-0002-9094-6769
Möhlenbruch, Markus A. http://orcid.org/0000-0002-5075-704X
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 27 May 2020
Accepted: 6 August 2020
First Online: 7 September 2020
Compliance with ethical guidelines
:
: C.S. Weyland, U. Neuberger, A. Potreck, J.A.R. Pfaff, S. Nagel and S. Schönenberger declare that they have no competing interests. M. Bendszus: activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: grants and personal fees from Bayer, Codman, Guerbet, Medtronic and Novartis; grants from the German Research Council (DFG), European Union, Hopp Foundation, Siemens, and Stryker; personal fees from BBraun, Böhringer Ingelheim, Roche, Teva, and Vascular Dynamics. Other relationships: disclosed no relevant relationships. M.A. Möhlenbruch: unrelated: board membership: Codman; consultancy: Medtronic, MicroVention, Stryker; Grants/Grants Pending: Balt*, MicroVention*; payment for lectures: Medtronic, MicroVention, Stryker. *Money paid to the institution.
: This study was approved by the local ethics committee (Ethikkommission der Universität Heidelberg). Informed consent was waived due to the retrospective nature of this study. The study was conducted following the STROBE criteria.